Abiopharma

🔍 Remer Eric Richard (Director)

Company: EverCommerce Inc. (EVCM)

Report Date: 2026-06-16

Detailed Transactions and Holdings:

• Sold 4,000,000 shares of Common Stock (Direct)
  Date: 2026-06-16 | Code: J | equity_swap_involved: 0 | shares_owned_after: 1,148,663.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,644 shares of Common Stock at $9.0534 per share (Direct)
  Date: 2026-06-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 5,751,607.00 | transaction_form_type: 4 | Footnotes: F2, F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-16 | Code: H | nature_of_ownership: By Remer Family Trust | shares_owned_after: 35,000.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-16 | Code: H | nature_of_ownership: By EMJ Remer Family Trust | shares_owned_after: 1,000,000.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-16 | Code: H | nature_of_ownership: By Family Trust 1 | shares_owned_after: 28,999.00

Footnotes:

• F1: Represents a pro-rata, in-kind distribution by Buckrail Partners, LLC, without additional consideration, to its members. In connection with such distribution, the Reporting Person directly acquired 3,012,964 shares of EverCommerce Inc. (the "Company") Common Stock in a transaction exempt from reporting pursuant to Rule 16a-9(a).
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.27. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• REMARKS: All sale transactions reported herein were made pursuant to a Rule 10b5-1 trading plan dated June 12, 2025.